373 results on '"Lee, Stella E"'
Search Results
2. The Impact of the Microbiome in Chronic Rhinosinusitis with Nasal Polyps
3. The Impact of Ambient and Wildfire Air Pollution on Rhinosinusitis and Olfactory Dysfunction
4. Air pollution, genetic factors, and chronic rhinosinusitis: A prospective study in the UK Biobank
5. Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study
6. Nasal polyp antibody-secreting cells display proliferation signature in aspirin-exacerbated respiratory disease
7. Iron bioavailability regulates Pseudomonas aeruginosa interspecies interactions through type VI secretion expression
8. Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosis
9. Clinical Assessment of Chronic Rhinosinusitis
10. A ready-to-use, thermoresponsive, and extended-release delivery system for the paranasal sinuses
11. SprayNPray: user-friendly taxonomic profiling of genome and metagenome contigs
12. Postoperative Care from the Rhinologic and Neurological Perspectives
13. Advances in controlled drug delivery to the sinonasal mucosa
14. Respiratory Infections and Anti-Infective Medication Use From Phase 3 Dupilumab Respiratory Studies
15. International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
16. Persistence and evolution of Pseudomonas aeruginosa following initiation of highly effective modulator therapy in cystic fibrosis
17. Effects of highly effective modulator therapy on the dynamics of the respiratory mucosal environment and inflammatory response in cystic fibrosis
18. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial
19. Current Evidence for Biologic Therapy in Chronic Rhinosinusitis with Nasal Polyposis
20. A thermoresponsive hydrogel system for long-acting corticosteroid delivery into the paranasal sinuses
21. Adult-onset asthma, allergy, and aspirin hypersensitivity associate with self-reported food avoidance.
22. Biologic Therapy in Pediatric Chronic Rhinosinusitis: A Systematic Review.
23. Optimizing cryopreservation of nasal polyp tissue for cellular functional studies and single-cell RNA sequencing.
24. Elexacaftor-tezacaftor-ivacaftor decreases pseudomonas abundance in the sinonasal microbiome in cystic fibrosis.
25. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials
26. What is the Role of Air Pollution in Chronic Rhinosinusitis?
27. 15-Lipoxygenase 1 in nasal polyps promotes CCL26/eotaxin 3 expression through extracellular signal-regulated kinase activation
28. Surgical Navigation in the Anterior Skull Base Using 3-Dimensional Endoscopy and Surface Reconstruction.
29. Impact of Dupilumab on Sinonasal Symptoms and Outcomes in Severe Chronic Rhinosinusitis With Nasal Polyps.
30. Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS‐24 and SINUS‐52.
31. Elexacaftor–tezacaftor–ivacaftor decreases pseudomonas abundance in the sinonasal microbiome in cystic fibrosis
32. Nasal polyp antibody secreting cells display proliferation signature in aspirin-exacerbated respiratory disease
33. Optimizing cryopreservation of nasal polyp tissue for cellular functional studies and single‐cell RNA sequencing
34. Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS‐24 and SINUS‐52
35. Evaluating treatment response to mepolizumab in patients with severe CRSwNP*
36. Immunomodulators in chronic rhinosinusitis
37. Management of Anaphylaxis
38. Managing chronic rhinosinusitis in severe asthma
39. Local cytokine levels associate with SNOT‐22 and UPSIT scores in chronic rhinosinusitis
40. Not just snot: Local inflammatory profiles in patients with aspirin‐exacerbated respiratory disease differ from patients with aspirin‐tolerant chronic rhinosinusitis
41. Monoclonal Antibodies for the Treatment of Nasal Polyps
42. Local cytokine levels associate with SNOT‐22 and UPSIT scores in chronic rhinosinusitis.
43. Not just snot: Local inflammatory profiles in patients with aspirin‐exacerbated respiratory disease differ from patients with aspirin‐tolerant chronic rhinosinusitis.
44. The relationship of sinus opacification, olfaction and dupilumab efficacy in patients with CRSwNP.
45. International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
46. Biologics for Nasal Polyps: Synthesizing Current Recommendations into a Practical Clinical Algorithm
47. New Concepts in Barrier Dysfunction in CRSwNP and Emerging Roles of Tezepelumab and Dupilumab
48. AJRA Special Issue on Nasal Polyps
49. Clinically meaningful changes in efficacy outcomes in chronic rhinosinusitis with nasal polyposis
50. Will nasal airway surgery improve my sense of smell? A prospective observational study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.